ARRIVENT BIOPHARMA, INC. (AVBP) Operating cash flow 2023–2025
ARRIVENT BIOPHARMA, INC. (AVBP) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$160.6MFY2025 · since FY2023: -$55.8M → -$160.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$160.6M | -128.7% |
| FY2024 | -$70.2M | -25.7% |
| FY2023 | -$55.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AVBP financial trends
AVBP RevenueAVBP Net incomeAVBP Net marginAVBP Gross profitAVBP Gross marginAVBP Operating incomeAVBP Operating marginAVBP Free cash flowAVBP Capital expendituresAVBP Return on equityAVBP Stock buybacksAVBP Dividends paidAVBP Total assetsAVBP Total liabilitiesAVBP Shareholders’ equityAVBP overview →